- Recommendation ID
- NG199/1
- Question
Oral teicoplanin compared with oral vancomycin or oral fidaxomicin for treating Clostridioides difficile infection: What is the clinical effectiveness, cost effectiveness and safety of oral teicoplanin 100 mg to 200 mg twice a day for 7 to 14 days compared with oral vancomycin or oral fidaxomicin for treating C. difficile infection in adults?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale section on choice of antibiotic.
Source guidance details
- Comes from guidance
- Clostridioides difficile infection: antimicrobial prescribing
- Number
- NG199
- Date issued
- July 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2021 |